Dosing of intravenous immunoglobulin in COVID-19 vaccine-induced immune thrombocytopenia and thrombosis

J Clin Pathol. 2023 Feb;76(2):143-144. doi: 10.1136/jcp-2022-208377. Epub 2022 Sep 29.

Authors

Siraj A Misbah¹, Sue Pavord², Mark Foster³

Affiliations

¹ Clinical Immunology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK siraj.misbah@ouh.nhs.uk.
² Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
³ Haematology, Medical Data Solutions and Services (MDSAS), Manchester, UK.

PMID: 36175122
DOI: 10.1136/jcp-2022-208377

No abstract available

Keywords: COVID-19; Immunoglobulins; THROMBOSIS; VACCINES.

Publication types

Letter

MeSH terms

COVID-19 Vaccines* / adverse effects
COVID-19* / prevention & control
Humans
Immunoglobulins, Intravenous / adverse effects
Purpura, Thrombocytopenic, Idiopathic* / chemically induced
Purpura, Thrombocytopenic, Idiopathic* / drug therapy
Thrombocytopenia* / chemically induced
Thrombosis* / chemically induced

Substances

COVID-19 Vaccines
Immunoglobulins, Intravenous